ROCK — Drug Target
All drugs that target ROCK — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- ADX-2191 · Aldeyra Therapeutics, Inc. · ROCK inhibitor · Ophthalmology
ADX-2191 is designed to inhibit the activity of Rho-associated protein kinase (ROCK), which is involved in various cellular processes including inflammation and cell proliferation.